# Observation for Patients With Asymptomatic CNS Metastatic Disease

> **NCT02866981** · PHASE2 · COMPLETED · sponsor: **The Cooper Health System** · enrollment: 33 (actual)

## Conditions studied

- Cancer
- Metastatic Cancer

## Interventions

- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT02866981
- **Lead sponsor:** The Cooper Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2017-12-01
- **Final completion:** 2017-12-01
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02866981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02866981, "Observation for Patients With Asymptomatic CNS Metastatic Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02866981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*